Young-adult normal FDG-PET database


About this study

The purpose of this study is to construct a young-adult normative FDG database that could be used with Cortex-ID and/or MIMneuro, enabling a quantifiable regional cortex map by using a single patient’s FDG scan. Here, we will conduct a preliminary study (n=10) to test the feasibility of the protocol and workflow.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:      

  1. Subjects who clinically considered normal and between the ages of 18 and 35, inclusive. 

Exclusion Criteria:     

  1. Subjects unable to lie down without moving for 20 minutes.
  2. Subjects whose glucose tests ≥200 mg/dL prior to the PET exams.
  3. Women who are pregnant or cannot stop breast feeding for 24 hours. Women of child-bearing potential must have a negative pregnancy test within 48 hours of the PET exams.
  4. Claustrophobic patients unable to tolerate the scans (no sedation can be offered).
  5. Due to the small bore size of the PET/MR scanner, BMI of 30 or higher will be excluded.
  6. Standard safety exclusionary criteria for MRI such as metallic foreign bodies, pacemaker, etc.
  7. Subjects with neurologic disease.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Paul Min, Ph.D.

Closed for enrollment

Contact information:

Sherry Klingerman CCRP

(507) 284-0451

More information


Publications are currently not available